QIAGEN Extends Exiqon Deadline

In its first quarter SEC filing, QIAGEN estimated the acquisition cost at approximately $100 million based on March 29 currency exchange rates. The deal is expected to close in the second quarter. (For Exiqon’s first quarter results, see page 12.)

Venlo, the Netherlands 5/19/16; Venlo, the Netherlands 6/8/16; Copenhagen, Denmark 6/8/16—For a third time, QIAGEN has extended its offer to acquire the outstanding shares of publicly held Exiqon (see IBO 3/31/16). The offer period has been extended to June 22, following previous deadlines of May 18 and June 2. On June 8, QIAGEN lowered the threshold of stockholder acceptance of the offer from 90% of share capital and voting rights to 89.20%. As of June 8, QIAGEN had received shareholder acceptances representing 89.21% of shares. QIAGEN expects the offer to be completed successfully. Upon the acquisition’s close, Exiqon will be delisted from the NASDAQ Copenhagen.

< | >